Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?

Subjects

Subjects :

Aged, 80 and over
Antineoplastic Agents therapeutic use
Benzamides
Dasatinib
Female
Flow Cytometry
Humans
Imatinib Mesylate
Immunophenotyping
In Situ Hybridization, Fluorescence
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Neoplasms, Second Primary drug therapy
Neoplasms, Second Primary pathology
Piperazines therapeutic use
Pyrimidines therapeutic use
Thiazoles therapeutic use
Genome, Human
Leukemia, Lymphocytic, Chronic, B-Cell diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Lymphoid Progenitor Cells
Myeloid Progenitor Cells
Neoplasms, Second Primary diagnosis
Neoplasms, Second Primary genetics
Neoplastic Stem Cells

Details

Language :

English

ISSN :

1527-7755

Volume :

30

Issue :

32

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

23008321

Full Text :

https://doi.org/10.1200/JCO.2012.42.6767